PMID: 7009959Dec 1, 1980Paper

Impaired plasma triglyceride clearance as a feature of both uremic and posttransplant triglyceridemia

Kidney International
E SavdieJ F Mahony

Abstract

After accurate plasma volume calculation, endogenous plasma very-low-density-lipoprotein (VLDL)-triglyceride turnover rates were measured in 20 undialyzed patients with chronic renal failure (CRF) and in 16 renal transplant recipients with stable graft function. When kinetic criteria were based on a group of healthy subjects (Vmax = 36.7 mumoles/hr/kg), it was clear that, on the whole, CRF patients had a reduced capacity for VLDL-triglyceride removal (Vmax = 14.0 mumoles/hr/kg), as did graft recipients (Vmax = 19.5 mumoles/hr/kg). In transplant recipients with impaired graft function, however, extremes of both under removal and over production of VLDL-triglycerides were observed. In CRF, defective clearance was accompanied by a reduction in postheparin lipoprotein and hepatic lipase activities, although there was no statistical relationship. Enzyme activities were not reduced, however, after transplantation, and the metabolic factors responsible for defective clearance were not clearly identified.

References

Jan 1, 1977·Kidney International·M L SanfelippoG M Reaven
Aug 1, 1977·Metabolism: Clinical and Experimental·R C GreggG M Reaven
Dec 22, 1977·The New England Journal of Medicine·R MordasiniH Greten
Apr 1, 1978·The American Journal of Medicine·L S IbelsR Weil
Aug 1, 1978·Kidney International·M L SanfelippoG M Reaven
Oct 1, 1979·Annals of Internal Medicine·D C CattranS A Fenton
Jan 1, 1979·Transactions - American Society for Artificial Internal Organs·G A CrawfordJ F Mahony
Aug 1, 1978·Metabolism: Clinical and Experimental·L VerschoorJ C Birkenhäger
Feb 22, 1975·British Medical Journal·J H StewartJ F Mahony
Nov 1, 1975·Metabolism: Clinical and Experimental·T MuraseG Steiner
Nov 1, 1965·The Journal of Clinical Investigation·G M ReavenJ W Farquhar
Apr 1, 1959·Physiological Reviews·M I GREGERSEN, R A RAWSON
Jul 1, 1960·The Journal of Clinical Investigation·R S YALOW, S A BERSON

❮ Previous
Next ❯

Citations

Dec 1, 1993·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·U Querfeld
Jul 1, 2008·Indian Journal of Clinical Biochemistry : IJCB·Pragna RaoA S Kanagasabapathy
Aug 31, 1992·Clinica Chimica Acta; International Journal of Clinical Chemistry·C L MalmendierH Bismuth
Dec 1, 1990·Baillière's Clinical Endocrinology and Metabolism·C D Short, P N Durrington
Jan 12, 2002·Kidney International·Diana M LeePetar Alaupovic
Sep 13, 2003·Kidney International·Berthil H C M T PrinsenMonique G M De Sain-Van Der Velden
Feb 12, 2004·Kidney International·Berthil H C M T PrinsenMonique G M de Sain-van der Velden
Jan 21, 2006·Seminars in Dialysis·Jia Liu, Mitchell H Rosner
Nov 3, 2010·Seminars in Dialysis·Robert E Cronin, Robert F Reilly
Dec 1, 1992·European Journal of Clinical Chemistry and Clinical Biochemistry : Journal of the Forum of European Clinical Chemistry Societies·A TelciU Eldegez
Jun 1, 1993·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·P O AttmanP Alaupovic
Dec 1, 1992·Kidney International·P O AttmanP Alaupovic
Sep 1, 1987·Kidney International·P O AttmanA Gustafson
Jun 1, 1992·Kidney International·T ShojiH Morii
Jan 1, 1991·Kidney International·G Appel
Jan 1, 1984·The Journal of Pediatrics·G ZillerueloJ Strauss
Aug 17, 2006·Therapeutic Apheresis and Dialysis : Official Peer-reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy·Tetsuo Shoji, Yoshiki Nishizawa
Mar 16, 2007·Journal of the American Society of Nephrology : JASN·Bonnie C H KwanAlfred K Cheung
Jan 1, 1982·Acta Medica Scandinavica·H E Norbeck, S Rössner
Feb 1, 1997·Scandinavian Journal of Clinical and Laboratory Investigation·M Arnadóttir
Dec 1, 1992·International Journal of Pancreatology : Official Journal of the International Association of Pancreatology·G MontaltoA Notarbartolo
Jan 1, 1997·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·P LeeJ Best

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.